You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mln8237

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Canada, United States (MLN8237, Irinotecan, Temozolomide)

Completed
Has Results
  • Neuroblastoma
  • MLN8237
  • +2 more
  • Los Angeles, California
  • +12 more
Jul 10, 2019

Head Neck Cancer Trial in Philadelphia (MLN8237, Cetuximab, Radiotherapy)

Completed
  • Head and Neck Cancer
  • MLN8237
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Aug 28, 2018

Prostate Cancer Trial (MLN8237)

No longer available
  • Prostate Cancer
  • MLN8237
  • (no location specified)
Apr 2, 2018

Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis (MLN8237, nab-Paclitaxel)

Completed
  • Adenocarcinoma
  • Pancreatic Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 9, 2018

Small Cell Prostate Cancer, Neuroendocrine Prostate Cancer, Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for

Completed
Has Results
  • Small Cell Prostate Cancer
  • +2 more
  • MLN8237
  • Chicago, Illinois
  • +7 more
Dec 18, 2017

Unspecified Childhood Solid Tumor, Excluding CNS, Neuroblastoma Trial (MLN8237)

Completed
  • Unspecified Childhood Solid Tumor, Excluding CNS
  • Neuroblastoma
  • MLN8237
  • (no location specified)
Feb 5, 2016